Results from a Phase 3 study showed that treating pulmonary arterial hypertension (PAH) patients with oral Opsumit (macitentan) improved both their physical and mental health, positively impacting their quality of life (QoL). PAH is a progressive disease characterized by the difficulty to breathe and recurrent fatigue. Several studies have shown that PAH affects a person’s mental…
A specific gene known as CYP2C44, more active in women with pulmonary hypertension (PH) than in men, may be a key factor in protecting them from more severe forms of the disease, according to results of a study performed with animal models. More women are diagnosed with pulmonary arterial hypertension…
Breathing exercises aimed at improving the respiratory system’s muscular strength and endurance can considerably benefit pulmonary hypertension (PH) patients and improve their overall life quality. Researchers in Greece in the article, “Benefits of inspiratory muscle training in patients with pulmonary hypertension: A pilot study,” published in the Hellenic Journal of Cardiology, reported…
Get regular updates to your inbox.